Fulton Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Fulton Bank's XBI Position: Q1 2020 in Review
Fulton Bank sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2020, closing a stake of 2,532 shares — an estimated $241K sold.
Fulton Bank first reported a position in XBI in Q1 2015 and held it in 20 quarters. The position peaked at $2.6M in Q4 2015. 459 funds tracked by Wall St. Rank hold XBI as of Q1 2020.
- Fulton Bank reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2020 after selling out during the quarter.
- Fulton Bank sold 2,532 State Street SPDR S&P Biotech ETF shares in Q1 2020, an estimated $241K.
- Fulton Bank first reported a position in State Street SPDR S&P Biotech ETF in Q1 2015 and held it in 20 quarters.
- Fulton Bank's State Street SPDR S&P Biotech ETF position peaked at $2.6M in Q4 2015.
- 459 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2020.
Based on Fulton Bank's 13F filing for Q1 2020, filed 3 Apr 2020.